The article expresses strong disagreement with the ruling from the Fifth Circuit Court of Appeals in Alliance for Hippocratic Medicine v. FDA. The ruling undermines the FDA's scientific and independent judgment and imposes restrictive limitations on access to medication abortion. Although mifepristone remains available due to a Supreme Court stay, the Fifth Circuit's ruling could significantly restrict women's access to healthcare and undermine the FDA's evidence-based approval process for safe and effective medications. The Department of Justice plans to seek Supreme Court review of the Fifth Circuit's decision. President Biden and Vice President Harris are committed to defending reproductive healthcare and will support the FDA's independent approval of mifepristone. The article emphasizes the ongoing fight for women's freedom to make decisions about their own bodies in the face of unprecedented attacks on women's health.